Alzheimer’s Drug Lecanemab’s Positive Phase 3 Data Could Lead To Loosening Of Medicare Coverage Restrictions Read more
Inflation Reduction Act Provision Aims To Further Spur Biosimilar Uptake With Temporary Add-On Payment In Medicare Part B Read more